Bionik Laboratories Corp. financial data

Location
Watertown, MA
Fiscal year end
31 March
Latest financial report
10-K - Q1 2023 - 21 Jun 2023

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 160 % +91.9%
Quick Ratio 60.9 % +3.4%
Debt-to-equity -34,842 % -47.4%
Return On Equity 46,191 %
Return On Assets -133 % -1.5%
Operating Margin -267 % +65.9%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 12,480,431 shares +84.4%
Common Stock, Value, Issued 6,989 USD +1.6%
Weighted Average Number of Shares Outstanding, Basic 6,903,664 shares +18.1%
Weighted Average Number of Shares Outstanding, Diluted 6,903,664 shares +18.1%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 1,805,202 USD +41.7%
Cost of Revenue 815,325 USD +1.5%
Research and Development Expense 903,219 USD -9.5%
Selling and Marketing Expense 1,981,897 USD +3.2%
General and Administrative Expense 2,929,800 USD +4.4%
Operating Income (Loss) -4,825,039 USD +51.6%
Net Income (Loss) Attributable to Parent -4,946,024 USD +52.5%
Earnings Per Share, Basic -1 USD/shares +59.6%
Earnings Per Share, Diluted -1 USD/shares +59.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 427,383 USD -78.5%
Accounts Receivable, after Allowance for Credit Loss, Current 453,084 USD +64.9%
Inventory, Net 1,034,488 USD -13.1%
Assets, Current 2,777,558 USD -39.4%
Property, Plant and Equipment, Net 187,673 USD +1.1%
Operating Lease, Right-of-Use Asset 254,650 USD
Intangible Assets, Net (Excluding Goodwill) 34,000 USD
Goodwill 99,552 USD
Other Assets, Noncurrent 8,694 USD
Assets 3,362,127 USD -28.1%
Accounts Payable, Current 557,610 USD +82.8%
Employee-related Liabilities, Current 164,825 USD +42.1%
Accrued Liabilities, Current 1,387,150 USD +58.9%
Contract with Customer, Liability, Current 342,354 USD +9.1%
Liabilities, Current 2,309,181 USD +54.8%
Contract with Customer, Liability, Noncurrent 303,292 USD +18.2%
Operating Lease, Liability, Noncurrent 234,448 USD
Liabilities 5,002,715 USD +1.9%
Accumulated Other Comprehensive Income (Loss), Net of Tax 29,815 USD +6.1%
Retained Earnings (Accumulated Deficit) -100,348,345 USD -5.2%
Stockholders' Equity Attributable to Parent -1,640,588 USD -1.6%
Liabilities and Equity 3,362,127 USD -28.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Common Stock, Shares Authorized 13,000,000 shares 0%
Common Stock, Shares, Issued 6,878,162 shares +1.6%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 427,383 USD -78.5%
Operating Lease, Liability 256,516 USD
Depreciation 61,000 USD +52.5%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -4,944,305 USD +52.6%
Lessee, Operating Lease, Liability, to be Paid 329,869 USD
Property, Plant and Equipment, Gross 846,965 USD +22.8%
Operating Lease, Liability, Current 22,067 USD
Lessee, Operating Lease, Liability, to be Paid, Year Two 38,202 USD
Lessee, Operating Lease, Liability, to be Paid, Year One 36,989 USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 73,353 USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 38,202 USD
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5,000,000 shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 38,202 USD
Additional Paid in Capital 98,670,953 USD +0.38%
Deferred Tax Assets, Net of Valuation Allowance 16,425,300 USD +3.9%
Share-based Payment Arrangement, Expense 300,000 USD -25%
Interest Expense 107,150 USD -87%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%